NEW YORK (GenomeWeb) – Scientists from Toronto's Hospital for Sick Children (Sick Kids) have led a study showing several ways in which CRISPR/Cas9 genome editing could be used to treat hereditary diseases. Among the various applications demonstrated, the researchers used CRISPR/Cas9 to remove exon duplication in a gene affecting a patient with Duchenne Muscular Dystrophy (DMD), leading to the production of regular dystrophin.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.